Trial Profile
A first in human study of cannabis-based therapies for the treatment of early to moderate Parkinson's disease ("PD").
Status:
Planning
Phase of Trial:
Phase 0
Latest Information Update: 30 Dec 2019
Price :
$35
*
At a glance
- Drugs Marijuana (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; First in man
- Sponsors GB Sciences
- 20 Dec 2019 According to a GB Sciences media release, the company is planning to initiate this study in early 2020.
- 12 Apr 2018 New trial record
- 10 Apr 2018 According to a GB Sciences media release, company is planning to file an Exploratory IND application to the US FDA. This study is expected to start in early 2019.